Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke

C Yang, KE Hawkins, S Doré… - American Journal of …, 2019 - journals.physiology.org
As part of the neurovascular unit, the blood-brain barrier (BBB) is a unique, dynamic
regulatory boundary that limits and regulates the exchange of molecules, ions, and cells …

Is there new hope for therapeutic matrix metalloproteinase inhibition?

RE Vandenbroucke, C Libert - Nature reviews Drug discovery, 2014 - nature.com
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that form a family of
24 members in mammals. Evidence of the pathological roles of MMPs in various diseases …

[HTML][HTML] An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity

Y Ji, Q Gao, Y Ma, F Wang, X Tan, D Song… - Pharmacological …, 2023 - Elsevier
Rapid upregulation of matrix metalloproteinase 9 (MMP-9) leads to blood-brain barrier
(BBB) breakdown following stroke, but no MMP-9 inhibitors have been approved in clinic …

Pathogenesis of brain edema and investigation into anti-edema drugs

S Michinaga, Y Koyama - International journal of molecular sciences, 2015 - mdpi.com
Brain edema is a potentially fatal pathological state that occurs after brain injuries such as
stroke and head trauma. In the edematous brain, excess accumulation of extracellular fluid …

Matrix metalloproteinases in the brain and blood–brain barrier: versatile breakers and makers

RG Rempe, AMS Hartz, B Bauer - Journal of Cerebral Blood …, 2016 - journals.sagepub.com
Matrix metalloproteinases are versatile endopeptidases with many different functions in the
body in health and disease. In the brain, matrix metalloproteinases are critical for tissue …

Nanotechnological advances for the delivery of CNS therapeutics

HL Wong, XY Wu, R Bendayan - Advanced drug delivery reviews, 2012 - Elsevier
Effective non-invasive treatment of neurological diseases is often limited by the poor access
of therapeutic agents into the central nervous system (CNS). The majority of drugs and …

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

GA Rosenberg - The Lancet Neurology, 2009 - thelancet.com
Matrix metalloproteinases (MMPs) and proteins containing a disintegrin and
metalloproteinase domain (ADAM) are important in neuroinflammation, and recent studies …

Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia

E Candelario-Jalil, Y Yang, GA Rosenberg - Neuroscience, 2009 - Elsevier
Regulation of the extracellular matrix by proteases and protease inhibitors is a fundamental
biological process for normal growth, development and repair in the CNS. Matrix …

Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview

SR Archie, A Al Shoyaib, L Cucullo - Pharmaceutics, 2021 - mdpi.com
The blood-brain barrier (BBB) is a fundamental component of the central nervous system
(CNS). Its functional and structural integrity is vital to maintain the homeostasis of the brain …

[HTML][HTML] To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition

JA Jacobsen, JLM Jourden, MT Miller… - Biochimica et Biophysica …, 2010 - Elsevier
This short review highlights some recent advances in matrix metalloproteinase inhibitor
(MMPi) design and development. Three distinct approaches to improved MMP inhibition are …